Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-3305
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment ; volume:9 ; number:1 ; day:14 ; month:11 ; year:2016 ; pages:1-12 ; date:12.2016
Parasites & vectors ; 9, Heft 1 (14.11.2016), 1-12, 12.2016
- Creator
-
Kamga, Guy-Roger
- Contributor
-
Dissak-Delon, Fanny N.
Nana-Djeunga, Hugues C.
Biholong, Benjamin D.
Mbigha-Ghogomu, Stephen
Souopgui, Jacob
Zoure, Honorat G. M.
Boussinesq, Michel
Kamgno, Joseph
Robert, Annie
SpringerLink (Online service)
- DOI
-
10.1186/s13071-016-1868-8
- URN
-
urn:nbn:de:1111-201612071464
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kamga, Guy-Roger
- Dissak-Delon, Fanny N.
- Nana-Djeunga, Hugues C.
- Biholong, Benjamin D.
- Mbigha-Ghogomu, Stephen
- Souopgui, Jacob
- Zoure, Honorat G. M.
- Boussinesq, Michel
- Kamgno, Joseph
- Robert, Annie
- SpringerLink (Online service)
Other Objects (12)
Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia
Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
Determinants of community-led ivermectin treatment adherence for onchocerciasis control in Western Ethiopia: a case-control study
Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia
Considering ivermectin for treatment of schistosomiasis
Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
Mass ivermectin treatment for Onchocerciasis: Lack of evidence for collateral impact on transmission of Wuchereria bancroftiin areas of co-endemicity
Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report
Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia
Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
Determinants of community-led ivermectin treatment adherence for onchocerciasis control in Western Ethiopia: a case-control study
Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia
Considering ivermectin for treatment of schistosomiasis
Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
Mass ivermectin treatment for Onchocerciasis: Lack of evidence for collateral impact on transmission of Wuchereria bancroftiin areas of co-endemicity
Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report
Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia
Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
Determinants of community-led ivermectin treatment adherence for onchocerciasis control in Western Ethiopia: a case-control study
Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia
Considering ivermectin for treatment of schistosomiasis
Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin
Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
Mass ivermectin treatment for Onchocerciasis: Lack of evidence for collateral impact on transmission of Wuchereria bancroftiin areas of co-endemicity